Abstract
Background
To determine the efficacy of combined intravitreal triamcinolone (TA) injection and laser photocoagulation in persistent macular edema after branch retinal vein occlusion (BRVO).
Methods
Follow-up analysis of a case series of 24 patients with macular edema after BRVO (15 of 24 non-ischaemic, 9 of 24 ischaemic). Patients received an intravitreal injection of 4 mg TA followed by laser photocoagulation within the previously edematous area, applied in one or two sessions. Standardized clinical examinations included best corrected visual acuity testing, anterior and posterior segment biomicroscopy, intraocular pressure, and optical coherence tomography (OCT). Fluorescein angiography was performed before treatment and 3 and 6 months later.
Results
Median visual acuity improved significantly from 0.58 logMAR (95%-confidence interval (KI): 0.54 – 0.75, decimal 0.27) at baseline to 0.41 logMAR (KI: 0.37 – 0.64, decimal 0.39) at 1 month (p = 0.001), 0.33 logMAR (KI: 0.32 – 0.62, decimal 0.47) at 3 months (p = 0.002), and 0.41 logMAR (KI: 0.33 – 0.67, decimal 0.39) at 6 months (p = 0.016). A gain of one or more logarithmic lines was evaluated in 16/24 eyes (67 %) and a gain of 3 lines or more in 8/24 eyes (33 %) at 6 months. Three eyes had lost more than 1 line during the follow-up period. Median change of visual acuity at 6 months was +2.0 lines (KI: 0.2 – 2.4). Median central foveal thickness (OCT-CFT) was 423 μm (KI: 378 – 456, n = 24) at baseline and decreased to 270 μm (KI: 249 – 311, n = 24) at 1 month (p < 0.0001), 265 μm (KI: 254 – 344, n = 24) at 3 months (p < 0.0001), and 266 μm (KI: 259 – 365, n = 18) at 6 months (p = 0.001).
Conclusions
Macular edema after BRVO can effectively be treated by a combination of intravitreal TA injection and subsequent laser photocoagulation. During a 6-month follow-up this combination treatment resulted in a significant reduction of central foveal thickness and improvement of visual acuity.
Similar content being viewed by others
References
The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282
Mitchel P, Smith W, Chang A (1996) Prevalence and association of retinal vein occlusion in Australia: The Blue Mountains Eye Study. Arch Ophthalmol 114:1243–1247
Greer DV, Constable IJ, Cooper RL (1980) Macular oedema and retinal branch vein occlusion. Aust J Ophthalmol 8:207–209, doi:10.1111/j.1442-9071.1980.tb00340.x
Özkiris A, Evereklioglu C, Erkilic K, Ilhan O (2005) The efficacy of intravitreal triamcinolone acetonide injection of persistent macular edema in branch retinal vein occlusion. Eur J Ophthalmol 15:96–101
Cekic O, Chang S, Tseng JJ, Barile GR, Del Piore LV, Weissmann H et al (2005) Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25:851–855, doi:10.1097/00006982-200510000-00006
Chen SD, Sundaram V, Lochhead J, Patel CK (2006) Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 141:876–883, doi:10.1016/j.ajo.2005.12.011
Jonas JB, Akkoyun I, Kamppeter B, Kreissing I, Degenring RF (2005) Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 19:65–71, doi:10.1038/sj.eye.6701395
Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL (2007) Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 27:419–425, doi:10.1097/IAE.0b013e318030e77e
Tang WM, Han DP (2000) A study of surgical approaches to retinal vascular occlusions. Arch Ophthalmol 118:138–143
Mason J, 3rd, Feist R, White MJ et al (2004) Sheathotomy to decompress branch retinal vein occlusionA matched controlled study. Ophthalmology 111:540–545, doi:10.1016/j.ophtha.2003.05.032
Saika S, Tanaka T, Miyamoto T et al (2001) Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 239:729–732, doi:10.1007/s004170100344
Fekrat S, Goldberg MF, Finkelstein D (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central or branch vein occlusion. Arch Ophthalmol 116:43–52
Avitabile T, Longo A, Reibaldi A (2005) Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 140:695–702
Parodi M, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024–1027, doi:10.1007/s004170050339
Shilling JS, Jones CA (1984) Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 68:196–198, doi:10.1136/bjo.68.3.196
Chen SD, Lochhead J, Patel CK, Frith P (2004) Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 88:154–155, doi:10.1136/bjo.88.1.154
Jonas JB (2006) Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res 38:218–245, doi:10.1159/000093796
Lee H, Shah GK (2005) Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 25:551–555, doi:10.1097/00006982-200507000-00001
Williamson TH, O’Donnell A (2005) Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 139:860–866, doi:10.1016/j.ajo.2005.01.001
Patel PJ, Zaheer I, Karia N (2008) Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occulsion. Eye 22:60–64, doi:10.1038/sj.eye.6702518
Özkiris A, Evereklioglu C, Erkilic K, Dogan H (2006) Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion. Eye 20:13–17, doi:10.1038/sj.eye.6701803
Hayashi K, Hayashi H (2005) Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 139:972–982, doi:10.1016/j.ajo.2004.12.087
Yepremyan M, Wetz FD, Tivnan T, Eversman L, Marx JL (2005) The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 15:96–101
Campochiaro PA, Hafiz G, Shah SM, Nguyen QD et al (2008) Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 16:791–799, doi:10.1038/mt.2008.10
Kriechbaum K, Michels S, Prager F et al (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518–522, doi:10.1136/bjo.2007.127282
Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, Evans T, Costa RA, Cardillo J, (PACORES): Pan-American Collaborative Retina Study Group (2008) Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 28:212–219
Gündüz K, Bakri SJ (2008) Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Eye Mar 14 [Epub ahead of print]
Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R et al (2008) Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 92:351–355, doi:10.1136/bjo.2007.123513
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riese, J., Loukopoulos, V., Meier, C. et al. Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246, 1671–1676 (2008). https://doi.org/10.1007/s00417-008-0898-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0898-0